Contract manufacturer of autoinjectors and pen injectors for pharma
SHL Medical manufactures self-injection systems for pharmaceutical partners globally, operating across 5,001–10,000 employees with sites in Asia, Europe, and North America. The hiring mix—dominated by manufacturing (45) and engineering (35) roles, with accelerating velocity and notable leadership openings in platform product and investigation—signals active capacity expansion and equipment modernization. Tech stack reflects a manufacturing-operations organization: SAP for ERP, ServiceNow + BMC Remedy for IT service management, MES for factory control, plus emerging Python + FastAPI + Azure ML adoption, suggesting early-stage moves toward predictive maintenance and process optimization.
Notable leadership hires: Lead Investigator, Platform Product Lead
SHL Medical designs and manufactures self-injection systems—autoinjectors and pen injectors—for pharmaceutical and biotech customers worldwide. The company provides end-to-end support spanning device design, development, large-scale manufacturing, final assembly, labeling, and packaging. Headquartered in Zug, Switzerland, and founded in 1989, SHL operates manufacturing and assembly facilities across Asia, Europe, and North America. The product portfolio centers on proven device platforms that enable pharma partners to bring combination drugs to market while supporting patient independence. Active projects include process validation, capacity expansion, new equipment development, tech transfer, and design work on complex medical device combinations.
SHL Medical manufactures self-injection systems, including autoinjectors and pen injectors, for pharmaceutical and biotech companies. The company offers design, development, and large-scale manufacturing, including final assembly, labeling, and packaging.
SHL Medical is headquartered in Zug, Switzerland. The company operates manufacturing and assembly sites across Asia, Europe, and North America.
Other companies in the same industry, closest in size